Mike Siani-Rose

Mr. Siani-rose has 20+ years of experience in regenerative medicine, biotechnology and bioinformatics. At Cannformatics, he provides project leadership for strategic partnerships and leadership on computational biology and computational chemistry. He has been a project management consultant to Pharma/Biotech, directing projects that reach broadly across manufacturing organizations. Previously, as President and Founder of Theregen he raised $10M and led the company from preclinical through IND and two Phase 1 clinical trials for the implantable Anginera epicardial patch. He has extensive expertise in computational chemistry, drug discovery and bioinformatics from positions at Chiron Corporation (now Novartis), Kosan Biosciences and Affymetrix.

Mike has 45+ publications and ten issued patents in drug discovery, laboratory automation, bioinformatics, and regenerative medicine. He received his BS in Chemical Engineering from the University of Rochester, did graduate work in Computer Science at UCSD, and attended the BioExecutive Institute in the Haas School of Business at UC Berkeley.